Home - Products - Angiogenesis - CDK - BML-259

BML-259

CAS No. 267654-00-2

BML-259( CAY10554 )

Catalog No. M28107 CAS No. 267654-00-2

BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	39	Get Quote
10MG	69	Get Quote
25MG	155	Get Quote
50MG	264	Get Quote
100MG	462	Get Quote
500MG	981	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

BML-259
Note

Research use only, not for human use.
Brief Description

BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
Description

BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.(In Vitro):BML-259 prevents a large population of cells from NAC-evoked cell death.
In Vitro

BML-259 (10 μM) protects large population of cells against non-Aβ component of Alzheimer's disease amyloid (NAC)-evoked cell death.
In Vivo

——
Synonyms

CAY10554
Pathway

Angiogenesis
Target

CDK
Recptor

Antifungal|Antiviral
Research Area

——
Indication

——

Chemical Information

CAS Number

267654-00-2
Formula Weight

260.36
Molecular Formula

C14H16N2OS
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 125 mg/mL (480.12 mM)
SMILES

O=C(NC1=NC=C(S1)C(C)C)CC=2C=CC=CC2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Freitas-Silva O, et al. Tracing fungi secondary metabolites in Brazil nuts using LC-MS/MS. Drug Metab Lett. 2011 Aug;5(3):150-5.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CDK inhibitor E9

CDK inhibitor E9 is a novel CDK inhibitor that can overcomes ABC-mediated resistance of THZ1, functions as a potent, non-covalent inhibitor of CDK9 and a covalent inhibitor of CDK12.
NSC 625987

NSC 625987 is a potent, selective CDK4 inhibitor with IC50 of 0.2 uM, displays >500-fold selectivity over CDK2 (IC50 >100 uM for cdc2/cyclin A, cdk2/cyclin A and cdk2/cyclin E).
MC180295

MC180295 (MC-180295, MC 180295) is a novel potent, highly selective CDK9 inhibitor with IC50 of 5 nM

Sign In Join Free